Data Reveals JAK Inhibitor Traction for RA
IGEM Therapeutics awarded Best Start-up Biotech Company at the UK's OBN Awards
Digital Therapeutics Alliance Boosts European Presence
Getting Where You Need to Go
As this year's installment of our Emerging Pharma Leaders shows, the current roadmap for a career in biopharma requires its own "Waze"-like navigation.
CPhI Announces Pharma Award Winners
Grand Prize Winner of Astellas Oncology C3 Prize Announced
New Partnership Creates UK’s Largest Science & Technology Property Platform
Take of FDA Fast Lanes Fig 2
Take Up of FDA Fast Lanes Fig 1
Take of FDA Fast Lanes Fig 3
Janssen Expands Manufacturing Facility to Meet Growing Needs
Driving Access to the Most Efficient Form of Healthcare
A look at the pharmaceutical value chain and how pricing concerns and patient centricity fits in to improving access.
Applying Real-World Evidence to Rare Disease Drug Development
Pharmaceutical Executive, October 2018 Issue (PDF)
Click the title above to open the Pharmaceutical October 2018 issue in an interactive PDF format.
FDA Launches Major Push for New Antimicrobials
The regulator teams with other health agencies on strategies to combat antibiotic resistance, reshape R&D incentive schemes.
Does being an orphan speed up FDA approval?
Targeting the Affluent Fig2
Targeting the Affluent Fig1
Targeting the Affluent Fig5
Targeting the Affluent Fig3
Targeting the Affluent Fig4
How DSCSA Changes the Licensing Landscape
A look at the Drug SUpply Chain Security Act and how it impacts serialization and third-party logistics licensing.
UK Research Partners Secure £1M Innovation Boost for Novel Deep Learning Drug Discovery Platform
Oncology Tool Provides Weekly Performance and Market Share Analytics
UK's Amryt to Open US Clinical Trial Sites for Epidermolysis Bullosa
Hospitals Back Generic Drug Production Venture
Hu-manity.co and IBM Partner for Personal Data Property Rights
HBA and Healthcare Companies Partner in Gender Parity Collaborative
FDA Supports More Focused Development of Targeted Pain Therapies
To help combat the nation’s opioid epidemic, FDA is promoting a more tailored approach to developing and testing effective analgesics, with the aim of bringing less addictive pain treatments to market more quickly.
Country Report: UK
Faced with looming uncertainties triggered by the upcoming Brexit, the United Kingdom’s life sciences sector, which constitutes one of the last big remaining bastions of British industry, is not about to rest on its laurels.
